BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18815164)

  • 1. Efficient sampling approaches to address confounding in database studies.
    Hanley JA; Dendukuri N
    Stat Methods Med Res; 2009 Feb; 18(1):81-105. PubMed ID: 18815164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.
    Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2006 May; 15(5):291-303. PubMed ID: 16447304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of disease risk scores in pharmacoepidemiologic studies.
    Arbogast PG; Ray WA
    Stat Methods Med Res; 2009 Feb; 18(1):67-80. PubMed ID: 18562398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case-crossover study design in pharmacoepidemiology.
    Delaney JA; Suissa S
    Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods in pharmacoepidemiology: an invited series.
    Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):453-4. PubMed ID: 15981303
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to combat with confounding by indication in observational studies of intended drug effects.
    McMahon AD
    Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inaccuracy of the administrative database: comparative analysis of two databases for the diagnosis and treatment of intracranial aneurysms.
    Woodworth GF; Baird CJ; Garces-Ambrossi G; Tonascia J; Tamargo RJ
    Neurosurgery; 2009 Aug; 65(2):251-6; discussion 256-7. PubMed ID: 19625902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Database research in pediatric urology.
    Yiee JH; Copp HL
    Curr Opin Urol; 2011 Jul; 21(4):309-13. PubMed ID: 21499106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of associations in pharmacoepidemiology.
    Kaufman DW
    Semin Hematol; 2008 Jul; 45(3):181-8. PubMed ID: 18582625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiology--an Irish perspective.
    Williams D; Feely J
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):641-5. PubMed ID: 11980254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bias and confounding: pharmacoepidemiological study using administrative database].
    Nojiri S
    Yakugaku Zasshi; 2015; 135(6):793-808. PubMed ID: 26028416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrumental variables: application and limitations.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Epidemiology; 2006 May; 17(3):260-7. PubMed ID: 16617274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the estimation and use of propensity scores in case-control and case-cohort studies.
    Månsson R; Joffe MM; Sun W; Hennessy S
    Am J Epidemiol; 2007 Aug; 166(3):332-9. PubMed ID: 17504780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
    Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.
    Bohn J; Eddings W; Schneeweiss S
    Am J Epidemiol; 2017 Mar; 185(6):501-510. PubMed ID: 28399565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of self-controlled designs in pharmacoepidemiology.
    Hallas J; Pottegård A
    J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacoepidemiology: definitions, problems, methodology].
    Bégaud B; Dangoumau J
    Therapie; 2000; 55(1):113-7. PubMed ID: 10860010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.